You don't think much of ACHM and GILD new replicase inhibitor because the lead one was halted after nephrotoxicity? I think the new one will enter into the clinic in mid 08. ACHM also has an HCV protease inhibitor in preclinical that has produced low-single-digit nano-molar activity in the replicon assay.